Eksigent, a developer of advanced low-flow fluid delivery for drug discovery and other life science applications, has announced a new distribution agreement with Sweden-based Crelab Instruments
The agreement covers sales and service of Eksigent's NanoLC HPLC product line in Sweden and Denmark.
Crelab Instruments, founded in 1995, specialises in automation, chromatography sales and support.
The company provides advanced laboratory equipment to customers in pharmaceutical research, biotech, hospitals, universities and research institutes as well as the food industry.
Crelab Instruments's solutions focus on front-end automation, custom systems and special automated applications.
"Crelab has a strong position in the LC/MS market in Sweden," commented David Weber, Eksigent's president and CEO.
"The addition of our unique NanoLC products will help them develop sales in new markets as well as meet the evolving needs of existing customers".
"The NanoLC 1D and 2D from Eksigent are a perfect complement to Crelab's product portfolio," stated German Cuellar, Crelab's president.
"The cooperation between Crelab and Eksigent fits Crelab's strategic plan to meet the new research needs of our customers".
Eksigent is a pioneer in low-flow fluid delivery systems that automate and accelerate proteomics, drug discovery, drug delivery and other life science applications.
Eksigent's core technologies include microscale pumping, microfluidic system design and microfabrication.
The company offers solutions for nanoscale liquid chromatography, high-performance capillary liquid chromatography and drug delivery.
